Picture of Cohance Lifesciences logo

COHANCE — Cohance Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Suven Pharmaceuticals Dec-Quarter Consol Net Profit Falls

Feb 6 (Reuters) - Suven Pharmaceuticals Ltd  SUVH.NS :
    * DEC-QUARTER CONSOL NET PROFIT 1.08 BILLION RUPEES VERSUS
1.60
BILLION RUPEES
    * DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 3.54 BILLION
RUPEES
VERSUS 3.92 BILLION RUPEES

Source text for Eikon:  ID:nBSEbF3XdQ 
Further company coverage:  SUVH.NS 
 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Cohance Lifesciences

See all news